. home.aspx

NEWS

home.aspx
   


Patient successfully treated for coronavirus in the US

February 11, 2020 / Conor Kavanagh
SHARESHARESHARE

The Ebola drug Remdesivir, made by Gilead Sciences, was given to an American who is 35 years old. The doctors reported that on 26 January his condition seemed to improve within a day, and by 30 January it had resolved most of the symptoms except a cough. However, Gilead feel this is not conclusive proof that it's an effective treatment. Ryan McKeel, a spokesperson for the company, said: “We do not have an appropriately robust understanding of the effect of this drug to warrant broad use at this time.” Timoth Sheahan, Assistant Professor of epidemiology at the Gillings School of Global Public Health at the University of North Carolina, has also called for further research saying: “I think starting a clinical trial is essential for determining if this drug will work.”